{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nonoxynol root_names_name in Any Name (approximate match)
Status:
Investigational
Source:
INN:dargistotug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sifarobocept [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:dafsolimab setaritox [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04590326: Phase 1/Phase 2 Interventional Recruiting Ovarian Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:tarcocimab tedromer [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04305041: Phase 1/Phase 2 Interventional Active, not recruiting Melanoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04699630: Phase 2 Interventional Active, not recruiting Metastatic Breast Cancer
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03586830: Phase 2 Interventional Completed Obesity and Diabetes Mellitus, Type 2
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03650348: Phase 1 Interventional Completed HER2-positive Breast Cancer
(2018)
Source URL:
Class:
PROTEIN